Treatment of eosinophilic esophagitis with inhaled corticosteroids.

PubWeight™: 2.05‹?› | Rank: Top 2%

🔗 View Article (PMID 9669733)

Published in J Pediatr Gastroenterol Nutr on July 01, 1998

Authors

W A Faubion1, J Perrault, L J Burgart, N N Zein, M Clawson, D K Freese

Author Affiliations

1: Department of Pediatrics, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Articles citing this

Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 1.90

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65

Advances in clinical management of eosinophilic esophagitis. Gastroenterology (2014) 1.48

Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2009) 1.44

Eosinophilic esophagitis. Dig Dis Sci (2009) 1.43

Eosinophilic esophagitis in infants and toddlers. Dysphagia (2006) 1.31

Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci (2009) 1.26

Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology (2014) 1.23

Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci (2003) 1.17

A Japanese case of eosinophilic esophagitis. J Gastroenterol (2006) 1.13

Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol (2009) 1.09

Therapeutic concepts in adult and paediatric eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2012) 0.94

Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) 0.93

Eosinophilic esophagitis. Gastroenterol Clin North Am (2012) 0.91

Eosinophilic esophagitis in Saudi children: symptoms, histology and endoscopy results. Saudi J Gastroenterol (2011) 0.88

Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunol Allergy Clin North Am (2015) 0.87

Esophageal trachealization: a feature of eosinophilic esophagitis. Saudi J Gastroenterol (2009) 0.86

Eosinophilic esophagitis: a newly established cause of dysphagia. World J Gastroenterol (2006) 0.85

Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Transl Immunology (2014) 0.85

Recent advances in the treatment of eosinophilic esophagitis. Expert Rev Clin Immunol (2010) 0.85

Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Am J Gastroenterol (2016) 0.85

Eosinophilic gastrointestinal diseases: review and update. ISRN Gastroenterol (2012) 0.84

Intermittent dysphagia for solids associated with a multiringed esophagus: clinical features and response to dilatation. Dysphagia (2007) 0.84

Eosinophilic esophagitis: historical perspective on an evolving disease. Gastroenterol Clin North Am (2014) 0.84

Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding. Semin Immunopathol (2012) 0.84

Management of refractory eosinophilic esophagitis. Dig Dis (2014) 0.82

International survey on evaluation and management of eosinophilic esophagitis. World Allergy Organ J (2012) 0.80

Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy. Dis Esophagus (2012) 0.80

Treatment of isolated gastric Crohn's disease with inhaled corticosteroids. Case Rep Gastroenterol (2008) 0.79

What are the roles of eosinophils in esophagitis? J Pediatr Gastroenterol Nutr (1998) 0.78

Diagnostic and therapeutic strategies for eosinophilic esophagitis. Clin Pract (Lond) (2014) 0.78

Esophageal granular cell tumor and eosinophilic esophagitis: two interesting entities identified in the same patient. Case Rep Gastroenterol (2008) 0.78

Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders. J Genet Syndr Gene Ther (2015) 0.76

Eosinophilic Esophagitis: update on treatment approaches. Hippokratia (2012) 0.75

Eosinophilic Esophagitis: an Emerging Clinicopathologic Disease of Children and Adults. Gastroenterol Hepatol (N Y) (2006) 0.75

Eosinophilic Esophagitis: Current Aspects of a Recently Recognized Disease. Gastroenterology Res (2010) 0.75

Sticky Steroids-In Search Of An Approved Treatment For Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr (2016) 0.75

TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis. J Allergy Clin Immunol (2015) 0.75

A Case of Eosinophilic Esophagitis Accompanying Familial Mediterranean Fever. Case Rep Gastrointest Med (2017) 0.75

Management of refractory eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2017) 0.75

Articles by these authors

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68

Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst (1997) 4.23

Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46

Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36

Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res (1996) 2.89

JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74

Origin and replication of defective interfering particles. Curr Top Microbiol Immunol (1981) 2.69

The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68

Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology (1999) 2.56

Brunner's gland hamartomas: clinical presentation and pathological features of 27 cases. Am J Gastroenterol (1995) 2.52

Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology (1978) 2.52

Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38

Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38

Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology (2001) 2.30

Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut (2002) 2.24

Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18

Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus. Virology (1972) 2.18

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Inverted complementary terminal sequences in single-stranded RNAs and snap-back RNAs from vesicular stomatitis defective interfering particles. J Gen Virol (1978) 2.02

Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96

Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer (2000) 1.95

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol (2001) 1.93

RNP template of vesicular stomatitis virus regulates transcription and replication functions. Cell (1983) 1.89

Sequence of a RNA templated by the 3'-OH RNA terminus of defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 1.80

E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat (1999) 1.65

Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg (1996) 1.65

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene (2003) 1.63

A simple classification of the risk in cardiac surgery: the first decade. Can J Anaesth (1993) 1.62

Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA. Am J Surg Pathol (2000) 1.60

Internal genome deletions in two distinct classes of defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1979) 1.57

Physiologic aspects of continence after colectomy, mucosal proctectomy, and endorectal ileo-anal anastomosis. Ann Surg (1982) 1.57

Forests in the long sweep of american history. Science (1979) 1.54

RNA virus genomes hybridize to cellular rRNAs and to each other. J Virol (1986) 1.51

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis (2006) 1.48

Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr (1994) 1.47

Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr (1998) 1.44

p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Cancer Res (1994) 1.42

Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clin Proc (1980) 1.41

Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg (1998) 1.39

Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer (2001) 1.35

Poliovirus genome RNA hybridizes specifically to higher eukaryotic rRNAs. Nucleic Acids Res (1985) 1.33

Variability of vesicular stomatitis virus autointerference with different host cells and virus serotypes. Virology (1972) 1.31

Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30

Cross-linked double-stranded RNA from a defective vesicular stomatitis virus particle. Virology (1976) 1.29

Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab (2000) 1.28

Initiation of vesicular stomatitis virus mutant polR1 transcription internally at the N gene in vitro. J Virol (1997) 1.27

Inhibitor of vesicular stomatitis virus transcriptase in purified virions. Nature (1974) 1.26

Fate of the rectal mucosa after rectal mucosectomy and ileoanal anastomosis. Dis Colon Rectum (1983) 1.23

Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat (2000) 1.22

Proteinase activity in purified animal viruses. Biochem Biophys Res Commun (1972) 1.21

Evidence for a glycoprotein in reovirus. Virology (1976) 1.21

HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res (2000) 1.20

Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr (1994) 1.19

Characterization of snap-back RNAs in vesicular stomatitis defective interfering virus particles. J Gen Virol (1978) 1.18

An efficient method for the extraction of DNA from formalin-fixed, paraffin-embedded tissue by sonication. Biotechniques (1991) 1.18

Stabilization of vesicular stomatitis virus L polymerase protein by P protein binding: a small deletion in the C-terminal domain of L abrogates binding. Virology (1996) 1.16

Generation of defective interfering particles in picornaviruses. Virology (1980) 1.15

Colectomy with rectal mucosectomy and ileoanal anastomosis in young patients. Its use for ulcerative colitis and familial polyposis. Arch Surg (1981) 1.15

Paget's disease of the perianal region--an aggressive disease? Dis Colon Rectum (1997) 1.13

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13

Constitutive phosphorylation of the vesicular stomatitis virus P protein modulates polymerase complex formation but is not essential for transcription or replication. J Virol (1996) 1.13

Total colectomy with rectal mucosectomy and ileoanal anastomosis for chronic ulcerative colitis in children and young adults. Mayo Clin Proc (1980) 1.11

Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol (2000) 1.11

Collagenous colitis: a clinicopathologic correlation. Mayo Clin Proc (1987) 1.10

Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res (1998) 1.09

Faithful and efficient in vitro reconstitution of vesicular stomatitis virus transcription using plasmid-encoded L and P proteins. Virology (1993) 1.09

Differential effect of ATP concentration on synthesis of vesicular stomatitis virus leader RNAs and mRNAs. J Virol (1987) 1.08

Campylobacter fetus ss. jejuni: a cause of massive lower gastrointestinal hemorrhage. Gastroenterology (1980) 1.07

Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection. Dig Surg (2000) 1.06

Early development of the neorectum by balloon dilations after ileoanal anastomosis. J Pediatr Surg (1981) 1.06

Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg (1998) 1.06

Enteric protein loss after the Fontan operation. Mayo Clin Proc (1994) 1.06

Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest (1998) 1.02

Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in women. Medicine (Baltimore) (2000) 1.01

Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr (2001) 1.01

Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis. Mayo Clin Proc (1987) 1.00

ATP dependence of vesicular stomatitis virus transcription initiation and modulation by mutation in the nucleocapsid protein. J Virol (1984) 0.99

Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis. Am J Gastroenterol (2001) 0.99

Crohn's disease in children: assessment of the progression of disease, growth, and prognosis. J Pediatr Surg (1980) 0.99

Phosphorylation of vesicular stomatitis virus M protein: evidence for a second virion-associated protein serine kinase activity. Virology (1989) 0.98

Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology (1993) 0.98

Redistributive properties of the vesicular stomatitis virus polymerase. Virology (1989) 0.97

Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation. J Pediatr (1987) 0.96

Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol (2013) 0.96

Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc (2001) 0.95

Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation (1997) 0.94

Liver transplantation for hepatoblastoma. The American experience. Ann Surg (1991) 0.94

The nucleotide sequence of the 5' terminus of vesicular stomatitis virus RNA. Nucleic Acids Res (1979) 0.94

hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol (2001) 0.94

Isolation and characterization of vesicular stomatitis virus PoIR revertants: polymerase readthrough of the leader-N gene junction is linked to an ATP-dependent function. Virology (1997) 0.93

Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc (2001) 0.93

Paucity of interlobular bile ducts: getting to know it better. Dig Dis Sci (1981) 0.92

Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med (1988) 0.92

A pediatric perspective on liver transplantation. Pediatr Clin North Am (1988) 0.92

Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation (2000) 0.91

Endoscopic intralesional steroid injections in the management of refractory esophageal strictures. Gastrointest Endosc (1995) 0.91

Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X. J Thorac Cardiovasc Surg (1996) 0.91